GLP-1 Weight-Loss Care in NYC & Philadelphia
Considering semaglutide or tirzepatide? W8MD offers in-person evaluation for prescription weight-management options at its Brooklyn and Philadelphia offices. Your provider will explain whether treatment is appropriate and discuss the specific product, expected costs and monitoring.
W8MD pricing and program highlights
Semaglutide programs
$29.99/week+
With insurance accepted for qualifying visits; self-pay from $59.99/week and up.
Tirzepatide programs
$45/week+
With insurance accepted for qualifying visits; self-pay from $69.99/week and up.
Medical program
Personalized
Nutrition, medications, behavior support, sleep evaluation and maintenance.
GLP-1 Weight Loss Injections: what patients should know
GLP-1 receptor agonists and related incretin therapies can help appetite, fullness and long-term weight management in eligible patients.
Which treatment fits your needs?
Your provider reviews your health history, medications and goals. Ask how the options differ and which factors influence the recommendation.
What does the quote include?
Request an explanation of program fees, visits, medication or pharmacy charges and follow-up. Insurance coverage for a medical visit does not establish medication coverage.
How will follow-up work?
Discuss who to contact with concerns and when to return. Dosing and treatment changes are decisions for your prescribing clinician.
Explore related care: Physician-Supervised Medical Weight Loss · Medical Weight Loss in Brooklyn, NYC · Medical Weight Loss in Northeast Philadelphia · Semaglutide Weight-Loss Care in NYC & Philadelphia · Tirzepatide Weight-Loss Care in NYC & Philadelphia · Phentermine Evaluation in NYC & Philadelphia.
How W8MD can help
- Review BMI, medical history, blood pressure, medications and contraindications.
- Discuss expected benefits, side effects, cost and insurance coverage.
- Combine medication with nutrition, activity, sleep and maintenance planning.
Helpful authoritative references
W8MD keeps content aligned with current public medical information while individual treatment decisions remain personalized.
FDA Zepbound and OSA
The FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, with diet and physical activity.
FDA Wegovy HD
The FDA approved a higher-dose 7.2 mg Wegovy HD option for weight loss and long-term maintenance in certain adult patients.
Home sleep testing
The American Academy of Sleep Medicine describes home sleep apnea testing as an alternative to polysomnography for appropriate uncomplicated adults.
Learn more on WikiMD.org
W8MD active offices
W8MD serves patients in New York City, Brooklyn, New Jersey, Connecticut, Greater Philadelphia, South Jersey, Pennsylvania and Delaware through active Brooklyn and Philadelphia offices, with telemedicine options when clinically appropriate.
Brooklyn / New York City
W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235
Greater Philadelphia
W8MD Philadelphia
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115
Ready to start with W8MD?
Call Brooklyn / NYC at 718-946-5500 or Philadelphia at 215-676-2334. You can also use the form below. Please do not include sensitive medical information in this form.
